How to Help Your Patients Save Money on Jublia: A Provider's Guide to Savings Programs

Jublia (efinaconazole 10% topical solution) is one of the most effective topical treatments for toenail onychomycosis, but its cost creates a significant adherence barrier for many patients. At retail, a single 4 mL bottle costs $923–$1,055. With 48 weeks of daily treatment required, patients without adequate coverage face total treatment costs exceeding $10,000 — a barrier that leads to prescription abandonment and undertreated infection.

As a prescriber, you have more power than you may realize to connect your patients with savings options that can make Jublia affordable. This guide covers every tool available in 2026, with practical guidance on how to implement each at the point of care.

The Scale of the Jublia Cost Problem

Without intervention, a high percentage of Jublia prescriptions will not be filled — or will be abandoned mid-course. Key cost factors:

Retail price: $923–$1,055 per 4 mL bottle

Treatment requires approximately 12 or more monthly refills over 48 weeks

Most Medicare Part D plans do not cover Jublia

Commercial plan formulary exclusions and step therapy add further delays and barriers

No widely available generic as of 2026 (broader competition expected ~2029–2030)

Savings Option 1: Ortho Dermatologics Rx Access Program — Your Most Powerful Tool

The Rx Access Program (OrthoRxAccess.com; 1-800-321-4576) is the manufacturer's savings program and should be your first recommendation for most patients. Here's what it offers by patient type:

Commercially insured with Jublia coverage: As little as $0 per fill

Commercially insured without Jublia coverage: As little as $65 per 4 mL bottle

Uninsured cash-pay patients: $75 per 4 mL bottle or $150 per 8 mL bottle (up to 12 uses)

Critical prescription routing note: The Rx Access Program is ONLY valid at Walgreens and participating independent pharmacies. If you electronically prescribe to a CVS, Rite Aid, or Walmart pharmacy, your patient will not be able to use this program. Route prescriptions to Walgreens or help patients locate a participating independent.

Eligibility exclusions: Not valid for patients on Medicare, Medicaid, TRICARE, VA, or any federal/state health insurance program. Also not valid in Massachusetts or Minnesota. Up to 12 uses per patient.

Savings Option 2: Bausch Health Patient Assistance Program — For Uninsured/Low-Income Patients

The Bausch Health Patient Assistance Program provides Jublia at no cost to eligible patients who are uninsured or underinsured and meet income requirements. This program requires prescriber participation — your office will need to help complete enrollment.

Access the program through BauschHealthCares.com. Consider assigning a front-desk staff member to manage PAP enrollment for patients who need it — the enrollment process is paperwork-intensive but can result in full-course access to Jublia at no cost.

Savings Option 3: GoodRx and Discount Card Programs

For patients who don't qualify for the Rx Access Program (including Medicare patients), GoodRx and SingleCare are useful backup options:

GoodRx: ~$741 per 4 mL bottle at most chain pharmacies. Available at GoodRx.com or the GoodRx mobile app.

SingleCare: ~$727 per 4 mL bottle. Available at SingleCare.com.

Consider printing a GoodRx card for Jublia and including it in the patient's visit summary or aftercare instructions. This small step can meaningfully increase fill rates.

Prior Authorization Strategy: Maximizing Approval Rates

For patients with commercial insurance that requires prior authorization, the quality of your PA submission directly impacts approval. Best practices to maximize approval:

Always include lab confirmation of diagnosis (KOH + culture, PAS stain, or PCR). PA requests without lab confirmation are more likely to be rejected.

Document specific contraindications or intolerances to oral terbinafine — this is the most common step therapy requirement

List prior treatments tried and failed (ciclopirox, OTC antifungals)

Submit the PA simultaneously with the prescription to avoid delays — processing can take 3–7 business days

Have a denial appeal strategy ready: written appeal letters supported by clinical evidence have a higher success rate than verbal appeals

Savings Option 4: 90-Day Supply Prescriptions

When insurance covers Jublia, writing for a 90-day supply can reduce the per-unit cost and the patient's number of pharmacy trips. Important: a 30-day quantity prescription cannot be filled as a 90-day supply — you must explicitly write for the 90-day quantity. This applies both to retail and mail-order pharmacy options. Some plans offer reduced copays for mail-order 90-day supplies.

Decision Framework: Choosing the Right Savings Path by Patient Type

Commercially insured, Jublia covered: → Rx Access Program at Walgreens (as low as $0); submit PA proactively

Commercially insured, Jublia NOT covered: → Appeal/PA request + Rx Access Program ($65/bottle) at Walgreens + GoodRx backup ($741/bottle)

Uninsured, able to pay ~$75/month: → Rx Access Program ($75/4mL bottle) at Walgreens/participating independents

Uninsured, low income: → Bausch Health Patient Assistance Program (potentially $0); consider oral terbinafine as alternative

Medicare patients: → GoodRx (~$741/bottle); Bausch PAP if eligible; strongly consider oral terbinafine or generic ciclopirox as covered alternatives

How medfinder Supports Prescription Adherence for Your Patients

Even with the right savings program in hand, patients often encounter friction at the pharmacy — the right location doesn't have Jublia in stock, or the specific Walgreens in their area is out of the 4 mL bottle. medfinder removes this friction by calling pharmacies near your patient to identify which ones can fill their prescription. For a long-course treatment like Jublia that requires 12 monthly fills, removing each refill barrier pays dividends in patient adherence and treatment completion.